vimarsana.com

Page 233 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Several patients on new unit at Vancouver General Hospital test positive for COVID-19 | iNFOnews

Dx Developers Hedge on SARS-Cov-2 Rapid Antigen Tests, Citing Conflicting FDA Messages

Modern Healthcare Illustration / Getty Images With rapid antigen tests for SARS-CoV-2 slow to come to market, officials at the US Food and Drug Administration have tried to signal via a number of public comments that the agency would be flexible regarding test performance requirements and use models. These indications of flexibility have largely failed to speed development and commercialization of rapid antigen tests, however, as test vendors, wary of falling short of agency requirements, have instead stuck to the more stringent specifications presented in the FDA s test templates. Early in the COVID-19 pandemic, rapid antigen tests were identified as a potentially key technology for slowing transmission of SARS-CoV-2 with calls for these tests growing as it became evident that molecular test capacity was not able to keep up with demand and was unlikely to ever reach a level where regular testing at population scale would be possible.

Sadistic inhumanity – shameless silence

On Wednesday, 3 March, the International Criminal Court (ICC) Prosecutor, Fatou Bensouda, confirmed the “initiation of an investigation respecting the Situation in Palestine”. This will only “cover crimes within the jurisdiction of the Court” over a very short period of time, since 13 June 2014. Bensouda note that “the decision to open an investigation followed a painstaking preliminary examination undertaken by my Office that lasted close to five years.” There is certainly nothing hasty or ill-considered about this ICC decision. It should be remembered that, in 2017, it was Fatou Bensouda who declined to commence an investigation into allegations made about the conduct of the Israeli Defence Forces in the case of the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.